Jump to main content.

Pesticide Registration Improvement Renewal Act (PRIA 2)
Fee Determination Decision Tree

Note: EPA no longer updates this information, but it may be useful as a reference or resource.

Decision Tree Resources:
Below is the fee for your selected Fee Category for
Fiscal Year 2011 & 2012

Action Code
FY11/FY12 Decision Time
New product; identical or substantially similar in composition and use to a registered product; registered source of active ingredient; selective data citation only for data on product chemistry and/or acute toxicity and/or public health pest efficacy, where applicant does not own all required data and does not have a specific authorization letter from data owner

Do you plan to request either of the following types of waivers?

50% waiver 50% waiver
75% waiver 75% waiver

To pay the fee shown above, go to http://www.pay.gov and follow the instructions.

How to submit your application directly to EPA.

Action Code Interpretation:

An application for registration of an end-use pesticide product that is substantially similar or identical in its uses and/or formulation to products that are currently registered or differ only in ways that would not significantly increase the risk of unreasonable adverse effects.  The applicant must identify the similar products for all active ingredients in the proposed product.  All applications require  the following: 

  • A data matrix is required with the application.
  • Product chemistry data (Group A and B) (2 pp, 105K, About PDFs) unless the product is identical.  In some cases product chemistry data can be satisfied as outlined in Pesticide Registration Notice 98-1 (9 pp, 22.3 MB, About PDF).
  • All inert ingredients must already be approved for the applicable uses in the product.
  • The active ingredient listed on the CSF must be an EPA registered product.
  •  In all cases, the applicant must identify the currently registered similar product for this category.
  • Acute toxicity, efficacy, public health pest efficacy, companion animal safety data and/or child resistant packaging data requirements must be addressed by using: 1) the cite-all method, or 2) selective data citation where the applicant does not own all required data and does not have a specific authorization letter from the data owner.  If review of data is needed, this application does not fall within this category.

The application is not in this category if efficacy, acute toxicity, companion animal safety, and/or child resistant packaging data are submitted and must be reviewed to support the application. The application does not fall into this category if it contains a request to waive any of these data.  An application that requires review of cited or submitted data other than product chemistry does not belong in this fee category.
An application proposed as a 100% re-packaged product does not fall within this category (see category R300).

Substantially similar: Product must have the same active ingredient, in substantially the same proportion, same chemical composition (solid, liquid, granular), and substantially similar inert ingredients as the already registered product.  In addition, substantially similar means that the proposed product bears the same use patterns.  Adding to or changing existing use patterns exclude the proposed product from treatment as a substantially similar product.  Deleting use patterns is acceptable.

Identical: Same composition and use patterns as a currently registered end use product.

Back      Go to the start of the Decision Tree

Publications | Glossary | A-Z Index | Jobs

Local Navigation

Jump to main content.